OnPoint Vision
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, OnPoint Vision sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
OnPoint Vision: 3 sponsored US clinical trials, 1 recruiting.
OnPoint Vision sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Refractive Error - Myopia, with 1 trials.
Upper-quartile sponsor footprint
OnPoint Vision sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
3 total, page 1 of 1
Evaluate the Safety and Effectiveness of the AccuraSee™ IOPCL for Secondary Implantation in the Capsular Bag to Improve Near and/or Intermediate Vision Following Previous Cataract Surgery
NCT06625749
Early Feasibility Study Using IOPCL MAG to Improve Near Vision in ARMD Subjects
NCT04984590
Early Feasibility Study to Evaluate the AccuraSee in Correcting Residual Refractive Errors After Cataract Surgery
NCT05113979
Therapeutic Areas
What is open in the OnPoint Vision pipeline
1 recruiting of 3 indexed (33% open); 2 completed (67%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Refractive Error - Myopia (1 trial), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
OnPoint Vision: open-pipeline peers nationwide
Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
OnPoint Vision sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 trials (± recruiting share)
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this OnPoint Vision page
3 registered trials is a research-attention snapshot, not an endorsement of OnPoint Vision or any single study.
- 1 of OnPoint Vision's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Refractive Error - Myopia is the condition OnPoint Vision studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Refractive Error - Myopia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
OnPoint Vision pipeline card: 3 registered trials from official public datasets.Report a data error.